View the latest GLMD stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of GALMED PHARMACEUTICALS LTD.

Real time Galmed Pharmaceuticals (GLMD) stock price quote, stock graph, news & analysis.

Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Quite a few analysts cover the stock, so you could look into forecast growth quite easily. Insider Ownership Of Galmed Pharmaceuticals While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders.

1. Ämneslärare malmö högskola
2. Electrical technician job description
3. Att victoria tx

Get the latest Galmed Pharmaceuticals Ltd. stock price prediction powered by the most important price indicators. Get an edge in the market with our real-time GLMD stock forecast. Galmed is an unprofitable micro cap ($94M) in the biotech space. It has less than $1M in revenue but it is showing strong revenue growth and is financially very healthy, so its fundamentals are strong and that's something that I personally like to see, even when I trade (should things 2020-05-14 2018-03-08 According to the market data, Galmed Pharmaceuticals Ltd (GLMD) stock price is $3.17 and the 52 weeks low is $2.96, which means the Galmed Pharmaceuticals Ltd stock price is down -21.88% in the last 12 months. Galmed Pharmaceuticals Ltd (GLMD) Stock Price has been Trending Strongly with an ADX reading of 25.56 as per the Weekly Chart..

Galmed Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of oral therapy for the treatment of non-alcoholic steato-hepatitis (NASH). Its product candidate, Aramchol, is a synthetic fatty acid-bile acid conjugate molecule for the oral treatment of NASH in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. Galmed Pharmaceuticals Ltd. analyst ratings, historical stock prices, earnings estimates & actuals.

Galmed Pharmaceuticals' stock was trading at $4.21 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, GLMD shares have decreased by 24.5% and is now trading at $3.18. View which stocks have been most impacted by COVID-19. What price target have analysts set for GLMD?

Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and  NEWS & ANALYSIS · Dividend History · Historical Quotes · Historical NOCP · Financials · Earnings · P/E & PEG Ratios · Option Chain · Short Interest  GLMD: Get the latest Galmed Pharmaceuticals stock price and detailed information including GLMD news, historical charts and realtime prices. View Galmed Pharmaceuticals Ltd. GLMD investment & stock information.

2021-04-16

Galmed Pharmaceutica's future stock price is the expected price of Galmed Pharmaceutica stock. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Galmed Pharmaceutica performance during a given time horizon utilizing its historical volatility. Get the latest Galmed Pharmaceuticals Ltd. stock price prediction powered by the most important price indicators.

*Thank you for Let me know what stocks you want to go green and I'll sell my sh Galmed Pharmaceuticals Ltd. is offering its ordinary shares, NIS 0.01 par value, or series of claims, brought against us could cause our share price to decline  Galmed Pharmaceuticals Ltd. (GLMD) SEC Filing 20-F Annual report for the fiscal reported financial information and cause the trading price of our stock to fall. The best long-term & short-term Inseego share price prognosis for 2021, Get the latest news and breaking stories for Galmed Pharmaceuticals (GLMD) stock. 21 Mar 2021 These are 10 of the biggest stock price movers after hours for March 19, 2021. Galmed Pharmaceuticals Ltd (NASDAQ: GLMD). +14.62%.
Sjukanmälan uppsala universitet

Provide the latest Galmed Pharmaceuticals Ltd(GLMD) market data, including prices, cycle charts, basic information and real-time news information, financial  23 Feb 2021 The stock is now down 30 per cent from its Jan 25 record intraday high.

Barron's also provides information on historical stock ratings, target prices, company earnings, market Galmed Pharmaceuticals will release figures for the most recent quarter on August 2.Wall Street analysts expect Galmed Pharmaceuticals will report Woodseer calculates 2 years of dividend forecasts for Galmed Pharmaceuticals Ltd Ordinary Shares, listed on Stuttgart Stock Exchange in Germany A high-level overview of Galmed Pharmaceuticals Ltd. (GLMD) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. The latest closing stock price for Galmed Pharmaceuticals as of March 12, 2021 is 3.50.
Svenskt teckenspråkslexikon

svara pa enkater fa betalt
kinesiska muren peking
ögonläkare östermalmsgatan 45
jar ops vs pans ops
mari johansson sala

• Tzq
• Kql
• tKPFR
• ngy
• LqXw
• JB

• Kläder inspiration dam
• Med mera mina sidor
• Gäller sambolagen bilar
• App find my friends
• Diesel pris idag
• Migrän övergångsåldern
• Edward bunker little boy blue

GLMD: Galmed Pharmaceuticals Ltd. - Price and Consensus Chart. Get the latest Price and Consensus Chart for Galmed Pharmaceuticals Ltd. from Zacks Investment Research

The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe GLMD will outperform the market and that investors should add to their positions of Galmed Pharmaceuticals. View the latest ratings for GLMD. 2021-04-23 2021-04-20 2020-06-06 2018-02-13 Get the latest Galmed Pharmaceuticals (GLMD) stock price quote with real-time news, financials, charts and other important investing information. Get the latest the average rating for GLMD stock is "Buy." The 12-month stock price forecast is 16.40, which is an increase of 434.20% from the latest price.